<DOC>
	<DOCNO>NCT01276392</DOCNO>
	<brief_summary>Actual clinical practice predominantly make use heparin ( systemically ) citrate regionally anticoagulation extracorporeal circulation renal replacement therapy . We aim find different anticoagulation strategy may lead different level platelet activation whole blood coagulation . Regarding coagulation activation , remain uncertain advantage one method . However , major interest minimize risk additional clotting activation via extracorporeal circulation usually critically ill patient .</brief_summary>
	<brief_title>Anticoagulation Activation - Comparison Continuous Renal Replacement Therapy</brief_title>
	<detailed_description />
	<mesh_term>Heparin</mesh_term>
	<criteria>Age &gt; 18 year , acute renal failure need continuous venovenous renal replacement therapy Age &lt; 18 year , pregnancy , contraindication one two anticoagulation method , miss inform consent disagreement progress study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>regional systemical anticoagulation</keyword>
	<keyword>continuous renal replacement therapy</keyword>
	<keyword>multiplate</keyword>
	<keyword>rotational thrombelastometry</keyword>
</DOC>